They already make the most potent weight-loss medication out there, Low Wang said, referring to Zepbound and Mounjaro
The REWIND trial, targeting cardiovascular events in T2DM participants without previous cardiovascular history, found that dulaglutide reduced cardiovascular outcomes, and was well tolerated [61]
[6], [7] Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent chronic liver disorder worldwide, with an increasing incidence driven by the global rise in obesity and metabolic syndrome
Reeves, Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges
While pharmaceutical GLP-1 agonists remain valuable tools in medical treatment, knowing how you can increase GLP-1 levels naturally, opens new pathways for proactive health management